HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Nakaraang pagsara
$0.64
Sakop ng araw
$0.64 - $0.70
Sakop ng taon
$0.51 - $0.88
Market cap
36.25M CAD
Average na Volume
11.43K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.83M | 150.74% |
Net na kita | -1.90M | -191.63% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.84M | -62.91% |
Kabuuang asset | 1.94M | -61.69% |
Kabuuang sagutin | 1.48M | 380.96% |
Kabuuang equity | 456.84K | — |
Natitirang share | 46.31M | — |
Presyo para makapag-book | 64.00 | — |
Return on assets | -180.81% | — |
Return on capital | -353.31% | — |
Cash Flow
Net change in cash
| (CAD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.90M | -191.63% |
Cash mula sa mga operasyon | -1.17M | -112.68% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | -1.17M | -111.54% |
Malayang cash flow | -419.32K | -17.42% |
Tungkol
Itinatag
2018
Headquarters
Website
